COMPANIES COVERED
Novo NordiskDownload FREE Report Sample
Download Free sampleAn insulin syringe aids in delivering insulin to diabetic patients in required doses. The insulin syringes consist of three parts-a needle, a barrel, and a plunger, and is available in various sizes. The size of the insulin syringe is selected based on the desired dosage of insulin to be administered to diabetic patients.
Insulin Syringes Market contains market size and forecasts of Insulin Syringes in global, including the following market information:
Global Insulin Syringes Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Insulin Syringes Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Insulin Syringes companies in 2021 (%)
The global Insulin Syringes market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
3/10 CC Syringe Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Insulin Syringes include Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon Ltd, Ypsomed AG, Wockhardt Ltd, Medtronic Plc, Abbott Laboratories and Animas Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Insulin Syringes manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Insulin Syringes Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Insulin Syringes Market Segment Percentages, by Type, 2021 (%)
3/10 CC Syringe
1/2 CC Syringe
1 CC Syringe
Others
Global Insulin Syringes Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Insulin Syringes Market Segment Percentages, by Application, 2021 (%)
Hospital
Homecare
Others
Global Insulin Syringes Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Insulin Syringes Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Insulin Syringes revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Insulin Syringes revenues share in global market, 2021 (%)
Key companies Insulin Syringes sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Insulin Syringes sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Sanofi
Eli Lilly and Company
Biocon Ltd
Ypsomed AG
Wockhardt Ltd
Medtronic Plc
Abbott Laboratories
Animas Corporation
F. Hoffmann-La Roche
BD
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
